Ascendis Pharma A/S (ASND)
NASDAQ: ASND · Real-Time Price · USD
251.27
-1.73 (-0.68%)
At close: Oct 30, 2026, 4:00 PM EDT
251.44
+0.17 (0.07%)
After-hours: Oct 30, 2026, 7:30 PM EDT
Ascendis Pharma Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Hold Initiates $268 | Hold | Initiates | $268 | +6.66% | Oct 26, 2026 |
| Citi | Citi | Buy Maintains $360 → $330 | Buy | Maintains | $360 → $330 | +31.33% | Oct 26, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $273 | Buy | Maintains | $273 | +8.65% | Oct 26, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $344 | Buy | Reiterates | $344 | +36.90% | Oct 19, 2026 |
| UBS | UBS | Buy Initiates $307 → $269 | Buy | Initiates | $307 → $269 | +7.06% | Oct 14, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Oct 10, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Oct 9, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $290 | Buy | Maintains | $290 | +15.41% | Oct 9, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.